<!DOCTYPE html>
<html lang="fa">
 <meta content="text/html;charset=utf-8" http-equiv="content-type"/>
 <head>
  <title>
   Etiology and prognosis of neonatal seizures
  </title>
  <link href="d/css/1.css" rel="stylesheet"/>
 </head>
 <body>
  <!-- Start Main Menu Area -->
  <br/>
  <br/>
  <br/>
  <br/>
  <div class="container">
   <div class="row">
   </div>
  </div>
  <section class="teacher-area ptb-10">
   <div class="container">
   </div>
   <section class="course-details-area ptb-60">
    <div class="container">
     <div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
      <h1 style="text-align:center">
       Etiology and prognosis of neonatal seizures
      </h1>
      <div class="utdArticleSection utdStyle" id="topicContent">
       <div id="topicTitle">
        Etiology and prognosis of neonatal seizures
       </div>
       <div class="authorSectionElem">
        <div class="authorsElementsLeft">
         <dl id="topicContributors">
          <dt>
           <span>
           </span>
           Author:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Renée Shellhaas, MD, MS
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Section Editors:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Douglas R Nordli, Jr, MD
           </a>
          </dd>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Joseph A Garcia-Prats, MD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Deputy Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            John F Dashe, MD, PhD
           </a>
          </dd>
         </dl>
        </div>
        <div class="authorsElementsRight">
         <div id="literatureReviewDate">
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             Literature review current through:
            </span>
            Jan 2024.
           </bdi>
          </div>
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             This topic last updated:
            </span>
            Jul 29, 2022.
           </bdi>
          </div>
         </div>
        </div>
       </div>
       <div id="topicWhatsNewContainer">
       </div>
       <div id="topicText">
        <p class="headingAnchor" id="H1">
         <span class="h1">
          INTRODUCTION
         </span>
         <span class="headingEndMark">
          —
         </span>
         Identifying the etiology of seizures is a primary clinical objective in the management of neonatal seizures. Accurate determination of the cause can lead to etiology-specific therapy and may limit central nervous system (CNS) dysfunction that would otherwise occur if the underlying condition was left untreated. Treatment of the underlying cause of seizures may also be necessary to control the seizures themselves.
        </p>
        <p>
         While there has been much discussion of the potential adverse effect of seizures on the immature brain, the most likely overriding factors that affect long-term outcome are the etiology of the seizures and the degree and distribution of brain injury caused by the underlying disturbance.
        </p>
        <p>
         This topic review will discuss neonatal seizures in terms of their etiologies and will focus on acute symptomatic seizures. The much less common neonatal epilepsy syndromes are discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/6198.html" rel="external">
          "Overview of neonatal epilepsy syndromes"
         </a>
         .)
        </p>
        <p>
         The clinical features, diagnosis, etiologic evaluation, and treatment of neonatal seizure are reviewed separately. (See
         <a class="medical medical_review" href="/z/d/html/6152.html" rel="external">
          "Clinical features, evaluation, and diagnosis of neonatal seizures"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/6201.html" rel="external">
          "Treatment of neonatal seizures"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H2">
         <span class="h1">
          CLASSIFICATION
         </span>
         <span class="headingEndMark">
          —
         </span>
         Almost all neonatal seizures may be categorized as "symptomatic" or "provoked" seizures, occurring as a consequence of a specific identifiable etiology  (
         <a class="graphic graphic_table graphicRef73867" href="/z/d/graphic/73867.html" rel="external">
          table 1
         </a>
         ) [
         <a href="#rid1">
          1
         </a>
         ]. Such seizures are considered acute and reactive and are therefore distinct from neonatal epilepsy. (See
         <a class="local">
          'Acute provoked (symptomatic) seizures'
         </a>
         below.)
        </p>
        <p>
         Although the majority (approximately 85 percent) of neonatal seizures occur as acute reactive events in response to identifiable etiologic factors, additional rare but distinct neonatal epilepsy syndromes are well recognized. These include:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Self-limited (familial) neonatal epilepsy
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Early infantile developmental and epileptic encephalopathy (EIDEE)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Additional etiology-specific epilepsies (eg,
         <em>
          KCNQ2
         </em>
         developmental and epileptic encephalopathy)
        </p>
        <p>
        </p>
        <p>
         The International League Against Epilepsy (ILAE) has classified epilepsy syndromes with the purposes of standardizing terminology and developing a more uniform understanding of the clinical features and consequences of these disorders [
         <a href="#rid2">
          2-5
         </a>
         ]. In the ILAE scheme, epilepsy syndromes are characterized by a cluster of clinical signs, symptoms, and laboratory findings that include seizure type, age of onset, etiology, precipitating factors, severity, ictal and interictal electroencephalography (EEG) findings, duration of the disorder, associated clinical features, chronicity, response to antiseizure medication therapy, and prognosis. (See
         <a class="medical medical_review" href="/z/d/html/14094.html" rel="external">
          "ILAE classification of seizures and epilepsy"
         </a>
         .)
        </p>
        <p>
         Neonatal seizures associated with these ILAE-designated syndromes are relatively rare. However, their identification is important in the management and prognosis of affected infants. (See
         <a class="medical medical_review" href="/z/d/html/6198.html" rel="external">
          "Overview of neonatal epilepsy syndromes"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/139238.html" rel="external">
          "Overview of infantile epilepsy syndromes"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H3">
         <span class="h1">
          ACUTE PROVOKED (SYMPTOMATIC) SEIZURES
         </span>
         <span class="headingEndMark">
          —
         </span>
         Symptomatic neonatal seizures (also called provoked neonatal seizures) may result from a wide range of possible etiologies [
         <a href="#rid6">
          6-9
         </a>
         ]. These can be organized by frequency  (
         <a class="graphic graphic_table graphicRef73867" href="/z/d/graphic/73867.html" rel="external">
          table 1
         </a>
         ) as well as relative acuity  (
         <a class="graphic graphic_table graphicRef76726" href="/z/d/graphic/76726.html" rel="external">
          table 2
         </a>
         ). Most etiologies can be broadly categorized as:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Neonatal encephalopathy and hypoxic-ischemic encephalopathy
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Acquired structural brain lesions, including ischemic and hemorrhagic stroke
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Metabolic disturbances
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Central nervous system (CNS) or systemic infections
        </p>
        <p>
        </p>
        <p>
         In a prospective multicenter study of 426 consecutive neonates with seizures in the United States, hypoxic ischemic encephalopathy was the most common etiology (38 percent), followed by ischemic stroke (18 percent) and intracranial hemorrhage (11 percent) [
         <a href="#rid9">
          9
         </a>
         ]. A similar etiologic distribution was reported in a separate European study [
         <a href="#rid10">
          10
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H481364217">
         <span class="h2">
          Neonatal encephalopathy
         </span>
         <span class="headingEndMark">
          —
         </span>
         Neonatal encephalopathy occurring as the result of hypoxia-ischemia is the most common cause of neonatal seizures [
         <a href="#rid9">
          9-11
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/6205.html" rel="external">
          "Etiology and pathogenesis of neonatal encephalopathy"
         </a>
         .)
        </p>
        <p>
         The diagnosis of neonatal encephalopathy and hypoxic-ischemic encephalopathy (HIE) can sometimes be difficult to make. Diagnostic criteria from the large therapeutic hypothermia trials [
         <a href="#rid12">
          12-14
         </a>
         ] are adopted by many institutions and include markers such as Apgar scores, need for resuscitation in the delivery room, recognition of clinical aspects of encephalopathy, altered state of alertness, acidosis, multisystem organ dysfunction, and seizures  (
         <a class="graphic graphic_table graphicRef96192" href="/z/d/graphic/96192.html" rel="external">
          table 3
         </a>
         ). These are reviewed in detail separately. (See
         <a class="medical medical_review" href="/z/d/html/6216.html" rel="external">
          "Clinical features, diagnosis, and treatment of neonatal encephalopathy", section on 'Evaluation'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/6216.html" rel="external">
          "Clinical features, diagnosis, and treatment of neonatal encephalopathy", section on 'Markers of acute hypoxia-ischemia'
         </a>
         .)
        </p>
        <p>
         Many neonatal seizures are not recognized clinically, and clinical features are poorly predictive of seizures in neonates with HIE. In a rigorous multicenter EEG monitoring study, approximately 50 percent of neonates who received therapeutic hypothermia for HIE had EEG-confirmed seizures, and the most accurate predictor of seizures was a severely abnormal interictal EEG background during the first hour of recording [
         <a href="#rid15">
          15
         </a>
         ]. Seizures in this setting usually occur within the first one to two days of birth and often remit after a few days [
         <a href="#rid11">
          11,15-18
         </a>
         ].
        </p>
        <p>
         Neonatal encephalopathy is discussed in detail separately. (See
         <a class="medical medical_review" href="/z/d/html/6205.html" rel="external">
          "Etiology and pathogenesis of neonatal encephalopathy"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/6216.html" rel="external">
          "Clinical features, diagnosis, and treatment of neonatal encephalopathy"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H2344432064">
         <span class="h2">
          Structural brain lesions
         </span>
         <span class="headingEndMark">
          —
         </span>
         Structural brain lesions associated with neonatal seizures include hemorrhage (intracerebral, subarachnoid, intraventricular), ischemic stroke (arterial, watershed, and venous distributions), and congenital anomalies of the brain. Hemorrhage and infarction may occur in isolation or may be the consequence of other etiologies such as CNS infection. Seizures are the most common sign of arterial ischemic stroke in newborn infants [
         <a href="#rid19">
          19
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/5051.html" rel="external">
          "Germinal matrix and intraventricular hemorrhage (GMH-IVH) in the newborn: Risk factors, clinical features, screening, and diagnosis"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/5000.html" rel="external">
          "Germinal matrix and intraventricular hemorrhage (GMH-IVH) in the newborn: Management and outcome"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/6157.html" rel="external">
          "Stroke in the newborn: Classification, manifestations, and diagnosis"
         </a>
         .)
        </p>
        <p>
         Neonatal seizures may also occur after infant heart surgery and are associated with increased risk for abnormalities on brain magnetic resonance imaging (MRI) and adverse neurodevelopmental outcomes [
         <a href="#rid20">
          20-22
         </a>
         ]. In two large series of infants who were monitored with video EEG in the postoperative period, the rate of electrographic neonatal seizures (85 to 100 percent of which were subclinical) ranged from 8 to 11 percent [
         <a href="#rid23">
          23,24
         </a>
         ]. Brain abnormalities, including diffuse periventricular leukomalacia or global hypoxic-ischemic injury, were found in 15 of 16 who had MRI [
         <a href="#rid23">
          23
         </a>
         ]. By contrast, another study utilizing specific anesthetic and surgical protocols reported a much lower seizure occurrence, 1 of 68 infants following cardiac surgery and cardiopulmonary bypass [
         <a href="#rid25">
          25
         </a>
         ].
        </p>
        <p>
         Congenital, developmental brain anomalies (particularly disorders of neuronal migration and organization) may cause neonatal seizures [
         <a href="#rid26">
          26
         </a>
         ]. Cerebral dysgenesis has become more widely recognized with increasing use of high-resolution MRI. These include both focal (eg, focal cortical dysplasia or schizencephaly) and diffuse (eg, lissencephaly) dysgenesis. Such seizures are most properly characterized as being due to neonatal-onset epilepsy. However, it is important to recognize that neonates with congenital brain malformations are also at risk for acute illnesses that predispose them to acute symptomatic seizures [
         <a href="#rid27">
          27
         </a>
         ]. Thus, any neonate with seizures should be evaluated for acute, treatable etiologies (even if epilepsy is suspected).
        </p>
        <p class="headingAnchor" id="H5">
         <span class="h2">
          Metabolic disturbances
         </span>
         <span class="headingEndMark">
          —
         </span>
         Potentially treatable metabolic etiologies include hypocalcemia, hypomagnesemia, and hypoglycemia. All newborns with suspected seizures should have a bedside glucose measurement, as well as laboratory testing for metabolic (electrolyte) disturbances. Typically, reversal of these abnormalities is sufficient to treat the acute symptomatic seizures, and anticonvulsant medications are not necessary. (See
         <a class="medical medical_review" href="/z/d/html/5060.html" rel="external">
          "Neonatal hypocalcemia"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/5053.html" rel="external">
          "Pathogenesis, screening, and diagnosis of neonatal hypoglycemia"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H63228154">
         <span class="h2">
          CNS infections
         </span>
         <span class="headingEndMark">
          —
         </span>
         Bacterial and viral infections of the CNS are important causes of seizures and other adverse sequelae [
         <a href="#rid28">
          28
         </a>
         ]. In addition, prenatal infections are potential risk factors for seizures. Any neonate with suspected seizures should be considered to have a systemic and/or CNS infection until proven otherwise and should have an immediate evaluation for infection. Often, empiric treatment is indicated until appropriate testing and cultures are completed. (See
         <a class="medical medical_review" href="/z/d/html/6017.html" rel="external">
          "Bacterial meningitis in the neonate: Neurologic complications"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/6000.html" rel="external">
          "Bacterial meningitis in children: Neurologic complications"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/6011.html" rel="external">
          "Overview of TORCH infections", section on 'Clinical features of TORCH infections'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H63228166">
         <span class="h2">
          Drug withdrawal or intoxication
         </span>
         <span class="headingEndMark">
          —
         </span>
         Neonates exposed to chronic opioids, alcohol, selective serotonin reuptake inhibitors, serotonin–norepinephrine reuptake inhibitors, benzodiazepines, and/or barbiturates may suffer a withdrawal syndrome in the first days of life that can include seizures.
        </p>
        <p>
         The clinical features and management of these syndromes are discussed in detail separately. (See
         <a class="medical medical_review" href="/z/d/html/5010.html" rel="external">
          "Prenatal substance exposure and neonatal abstinence syndrome (NAS): Clinical features and diagnosis"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/5016.html" rel="external">
          "Prenatal substance exposure and neonatal abstinence syndrome (NAS): Management and outcomes"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H369915303">
         <span class="h2">
          Inborn errors of metabolism
         </span>
         <span class="headingEndMark">
          —
         </span>
         Many of the inborn errors of metabolism can manifest seizures, especially in the neonatal and infantile period.
        </p>
        <p class="headingAnchor" id="H2966528375">
         <span class="h3">
          When to suspect a metabolic defect
         </span>
         <span class="headingEndMark">
          —
         </span>
         A metabolic defect should be suspected when seizures and encephalopathy begin several days postpartum following a normal pregnancy and delivery, absent postpartum complications [
         <a href="#rid29">
          29
         </a>
         ]. Other clues include a family history of consanguinity or early sibling death, physical signs such as organomegaly, cardiomyopathy, or hematologic abnormalities, and certain MRI and EEG findings  (
         <a class="graphic graphic_table graphicRef103003" href="/z/d/graphic/103003.html" rel="external">
          table 4
         </a>
         ). Selected laboratory tests may be useful in identifying a specific etiology  (
         <a class="graphic graphic_table graphicRef95363" href="/z/d/graphic/95363.html" rel="external">
          table 5
         </a>
         ). (See
         <a class="medical medical_review" href="/z/d/html/2912.html" rel="external">
          "Metabolic emergencies in suspected inborn errors of metabolism: Presentation, evaluation, and management", section on 'Seizures'
         </a>
         .)
        </p>
        <p>
         While the typical presentation usually includes poor feeding, lethargy, and respiratory distress after an initial symptom-free period of a few to several days, some infants present with isolated seizures. Inborn errors of metabolism should be suspected in the following settings [
         <a href="#rid29">
          29,30
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Prepartum fetal seizures (although this is a rare and difficult-to-determine finding)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Myoclonic seizure semiology
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Seizures refractory to conventional treatment
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Seizures associated with progressive deterioration of the infant's clinical status and worsening of the EEG background pattern
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Imaging findings of prominent brain atrophy, apparent hypoxic-ischemic injury without a history of insult, or diffuse cerebral edema
        </p>
        <p>
        </p>
        <p>
         The associated clinical features typical of inborn errors of metabolism are discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/2936.html" rel="external">
          "Inborn errors of metabolism: Epidemiology, pathogenesis, and clinical features"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/2912.html" rel="external">
          "Metabolic emergencies in suspected inborn errors of metabolism: Presentation, evaluation, and management"
         </a>
         .)
        </p>
        <p>
         A variety of pathogenic mechanisms may be responsible for seizures in these disorders [
         <a href="#rid29">
          29
         </a>
         ]. Those that involve accumulation of metabolites or deficiency of a vitamin or cofactor are most relevant in the neonatal period, and some have specific therapies available that may improve clinical outcomes significantly. (See
         <a class="local">
          'Cofactor and vitamin deficiencies'
         </a>
         below.)
        </p>
        <p>
         In disorders resulting from enzyme deficiencies, seizures may be caused by toxic substrates that accumulate proximal to the block or through activation of an alternate metabolic pathway. Examples include urea cycle defects, nonketotic hyperglycinemia, organic acidurias, and aminoacidopathies. Some of these disorders are included in newborn screening panels, but the composition of the panel varies from state to state and country to country. (See
         <a class="medical medical_review" href="/z/d/html/17216.html" rel="external">
          "Inborn errors of metabolism: Identifying the specific disorder"
         </a>
         .)
        </p>
        <p>
         Other inborn errors of metabolism commonly manifest seizures but the onset is typically later, in infancy or early childhood. These include disorders of energy deficiency (eg, glucose transporter-1 [GLUT1] deficiency, mitochondrial disorders, brain creatine deficiency) and those associated with structural brain changes causing neuronal dysfunction (eg, lysosomal diseases, disorders of glycogen metabolism, peroxisomal disorders, congenital disorders of glycosylation) [
         <a href="#rid29">
          29
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/6218.html" rel="external">
          "Seizures and epilepsy in children: Clinical and laboratory diagnosis"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/6151.html" rel="external">
          "Overview of peripheral nerve and muscle disorders causing hypotonia in the newborn", section on 'Inborn errors of metabolism'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/2930.html" rel="external">
          "Inborn errors of metabolism: Classification"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H753636662">
         <span class="h3">
          Cofactor and vitamin deficiencies
         </span>
         <span class="headingEndMark">
          —
         </span>
         Disorders that result in a cofactor or vitamin deficiency are important to recognize because they represent rare but treatable metabolic causes of refractory neonatal seizures. Examples include pyridoxine-dependent epilepsy (PDE) due to antiquitin deficiency, pyridoxamine 5’-phosphate oxidase (PNPO) deficiency, and biotinidase deficiency. Molybdenum cofactor deficiency is another rare cofactor deficiency with an emerging treatment option.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Pyridoxine-dependent epilepsy
         </strong>
         – Most cases of PDE are due to alpha-aminoadipic semialdehyde (alpha-AASA) dehydrogenase (also known as antiquitin, or ATQ) deficiency, an autosomal recessive inborn error of metabolism caused by defects in the
         <em>
          ALDH7A1
         </em>
         gene that lead to accumulation of alpha-AASA and pipecolic acid in plasma, urine and CSF [
         <a href="#rid31">
          31-34
         </a>
         ]. PNPO deficiency due to pathogenic variants in the PNPO gene is a related condition that lacks a biomarker aside from medically refractory neonatal seizures that are responsive to
         <a class="drug drug_pediatric" data-topicid="12753" href="/z/d/drug information/12753.html" rel="external">
          pyridoxine
         </a>
         or pyridoxal 5’-phosphate (PLP) [
         <a href="#rid35">
          35-37
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Antiquitin deficiency and PNPO deficiency have overlapping phenotypes. Most patients present with seizures in the neonatal period that can be focal, generalized, tonic, or myoclonic; some patients have infantile spasms [
         <a href="#rid34">
          34,38,39
         </a>
         ]. Up to half of children with PNPO deficiency are born at ≤37 weeks gestation [
         <a href="#rid35">
          35,36
         </a>
         ]. Most children have excellent seizure control with
         <a class="drug drug_pediatric" data-topicid="12753" href="/z/d/drug information/12753.html" rel="external">
          pyridoxine
         </a>
         or PLP supplementation but have a wide variety of neurodevelopmental problems [
         <a href="#rid40">
          40-43
         </a>
         ]. Lysine restricted diets, combined with arginine supplementation, may also be associated with milder neurodevelopmental phenotypes in affected children [
         <a href="#rid44">
          44,45
         </a>
         ]. Some children with antiquitin deficiency and pyridoxine-refractory seizures may respond to
         <a class="drug drug_pediatric" data-topicid="12544" href="/z/d/drug information/12544.html" rel="external">
          leucovorin
         </a>
         (folinic acid) [
         <a href="#rid46">
          46
         </a>
         ]. This has led to a sequence of empirical therapies and biochemical evaluation in infants with medically refractory neonatal seizures  (
         <a class="graphic graphic_algorithm graphicRef97078" href="/z/d/graphic/97078.html" rel="external">
          algorithm 1
         </a>
         ). (See
         <a class="medical medical_review" href="/z/d/html/6201.html" rel="external">
          "Treatment of neonatal seizures", section on 'Pyridoxine or PLP responsive seizures'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Biotinidase deficiency
         </strong>
         – Biotinidase deficiency due to pathogenic variants in the biotinidase gene may result in medically refractory neonatal seizures that are responsive to oral
         <a class="drug drug_pediatric" data-topicid="13071" href="/z/d/drug information/13071.html" rel="external">
          biotin
         </a>
         supplementation. In areas where biotinidase enzyme activity is not included in the newborn screening panel, a trial of biotin may be considered in addition to
         <a class="drug drug_pediatric" data-topicid="12753" href="/z/d/drug information/12753.html" rel="external">
          pyridoxine
         </a>
         , PLP, and/or
         <a class="drug drug_pediatric" data-topicid="12544" href="/z/d/drug information/12544.html" rel="external">
          leucovorin
         </a>
         . (See
         <a class="medical medical_review" href="/z/d/html/6201.html" rel="external">
          "Treatment of neonatal seizures", section on 'Biotinidase deficiency'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Molybdenum cofactor deficiency
         </strong>
         – Molybdenum cofactor deficiency (MoCD) is an autosomal recessive disorder that results from one of several single gene defects in the biosynthetic pathway of molybdenum cofactor [
         <a href="#rid47">
          47
         </a>
         ]. Approximately two-thirds of patients have MoCD type A, in which pathogenic variants in molybdenum cofactor synthesis gene 1 (MOSC1) result in the inability to synthesize the first intermediate in the pathway, cyclic pyranopterin monophosphate (cPMP), and the toxic accumulation of sulfites in blood and urine [
         <a href="#rid48">
          48
         </a>
         ]. Most patients present during the first few days of life with exaggerated startle, lethargy, intractable seizures, and autonomic dysfunction, a complex of symptoms that may resemble hypoxic ischemic encephalopathy. The disorder can be diagnosed by urine dipstick showing elevated sulfite levels and confirmed with urinary cPMP testing and mutational analysis. Supplementation of cPMP by daily intravenous infusions is a promising therapy in patients with MoCD type A (but not type B) with the potential to greatly improve neurodevelopmental outcomes when started sufficiently early and continued chronically [
         <a href="#rid49">
          49-52
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H8">
         <span class="h1">
          NEONATAL EPILEPSY SYNDROMES
         </span>
         <span class="headingEndMark">
          —
         </span>
         One of the neonatal epilepsy syndromes recognized by the International League Against Epilepsy (ILAE) is considered self-limited, as its name implies, and is associated with a relatively good prognosis: self-limited (familial) neonatal epilepsy [
         <a href="#rid5">
          5
         </a>
         ]. By contrast, early infantile developmental and epileptic encephalopathy (EIDEE) is categorized as a severe neonatal epilepsy syndromes because of its poor prognosis. Genetic etiologies are being increasingly recognized in patients with these syndromes [
         <a href="#rid27">
          27
         </a>
         ]. These syndromes are discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/6198.html" rel="external">
          "Overview of neonatal epilepsy syndromes"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/139238.html" rel="external">
          "Overview of infantile epilepsy syndromes"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H10">
         <span class="h1">
          PROGNOSIS
         </span>
         <span class="headingEndMark">
          —
         </span>
         The consequences of acute symptomatic seizures in neonates are determined mainly by the etiology of the seizures [
         <a href="#rid53">
          53,54
         </a>
         ]. Seizure burden and use of antiseizure medications may also have some impact, but this has yet to be fully defined [
         <a href="#rid55">
          55
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/6198.html" rel="external">
          "Overview of neonatal epilepsy syndromes"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H11">
         <span class="h2">
          Mortality and neurologic impairment
         </span>
         <span class="headingEndMark">
          —
         </span>
         There is a high incidence of early death (15 to 20 percent) associated with neonatal seizures [
         <a href="#rid9">
          9,56
         </a>
         ]. Risk factors for early death include hypoxic-ischemic etiology and high seizure burden. Mortality is even more common among preterm neonates, with mortality rates ranging from 25 to 35 percent [
         <a href="#rid57">
          57-59
         </a>
         ]. Even among survivors, there is an elevated risk of death throughout childhood, particularly for those who develop cerebral palsy and global developmental delay.
        </p>
        <p>
         Neurologic impairment, developmental delay, and postneonatal epilepsy are common among survivors [
         <a href="#rid54">
          54,60-66
         </a>
         ]. In studies with follow up ranging from 17 months to 10 years of age, the following long-term outcomes have been reported:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Abnormalities on neurologic examination (42 to 59 percent)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Global developmental delay (55 percent) [
         <a href="#rid61">
          61
         </a>
         ]
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Intellectual disability (20 to 40 percent) [
         <a href="#rid62">
          62,63
         </a>
         ]
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Cerebral palsy (25 to 43 percent) [
         <a href="#rid62">
          62,63,67
         </a>
         ]
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Learning disabilities (27 percent) [
         <a href="#rid63">
          63
         </a>
         ]
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         No neurologic abnormalities (22 to 35 percent) [
         <a href="#rid60">
          60
         </a>
         ]
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Epilepsy (13 to 27 percent) as discussed in the section that follows
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H12">
         <span class="h2">
          Postneonatal epilepsy
         </span>
         <span class="headingEndMark">
          —
         </span>
         Postneonatal epilepsy occurs in 13 to 27 percent of survivors of neonatal seizures [
         <a href="#rid60">
          60-64,68-71
         </a>
         ], and rates as high as 56 percent have been reported among populations with relatively high risk factors for central nervous system (CNS) dysfunction, such as more frequent seizures or status epilepticus [
         <a href="#rid72">
          72,73
         </a>
         ]. When seizures do occur in the postneonatal period, they most often emerge within the first six to nine months of life [
         <a href="#rid63">
          63,68,69
         </a>
         ]. However, the risk continues through early childhood [
         <a href="#rid74">
          74
         </a>
         ].
        </p>
        <p>
         Postneonatal epilepsy syndromes in survivors of neonatal seizures generally reflect the underlying etiology of the symptomatic seizures. As an example, a child with a focal brain lesion is most likely to develop focal epilepsy, while a child with diffuse brain injury may develop a generalized epilepsy syndrome [
         <a href="#rid75">
          75
         </a>
         ]. A relatively high rate of West Syndrome (infantile spasms, hypsarhythmia, and developmental disability) has been reported among survivors [
         <a href="#rid63">
          63,67,76
         </a>
         ].
        </p>
        <p>
         Risk factors for postneonatal epilepsy include:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Neonatal status epilepticus
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Requirement for more than one antiseizure medication to control neonatal seizures
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Seizure semiology other than focal clonic or focal tonic
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Abnormal neuroimaging
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Low birth weight
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Multifocal (versus focal) neonatal seizures
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Seizure spread to the contralateral hemisphere
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Persistently abnormal interictal EEG background
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Diagnosis of cerebral palsy during early childhood
        </p>
        <p>
        </p>
        <p>
         Specific risk factors for infantile spasms after acute symptomatic seizures are:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Severely abnormal neonatal EEG background or ≥3 days of EEG-confirmed neonatal seizures [
         <a href="#rid77">
          77
         </a>
         ]
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Deep gray or brainstem injury on neonatal brain MRI
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Abnormal tone on discharge neurologic exam
        </p>
        <p>
        </p>
        <p>
         To date, the only potentially protective intervention to prevent post-neonatal epilepsy is therapeutic hypothermia for neonates with hypoxic-ischemic encephalopathy (HIE). One study reported significantly lower post-neonatal epilepsy rates among neonates treated with therapeutic hypothermia compared with normothermia (19 versus 40 percent) [
         <a href="#rid78">
          78
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/6216.html" rel="external">
          "Clinical features, diagnosis, and treatment of neonatal encephalopathy"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H13">
         <span class="h2">
          Mechanisms of brain injury
         </span>
         <span class="headingEndMark">
          —
         </span>
         It is difficult to assess the relative contribution of various factors that may determine long-term outcome of those who have experienced neonatal seizures. Contributing factors may include the direct effect of seizures on the developing brain, the indirect effect of seizures, direct or indirect effects of antiseizure medications, and the effect of the underlying cause of seizures [
         <a href="#rid79">
          79
         </a>
         ]. Immature animals are more resistant to some types of seizure-induced brain injury than are older animals [
         <a href="#rid80">
          80
         </a>
         ]. However, animal models suggest that early-life seizures can lead to altered neuronal circuitry and may manifest as impaired learning and memory.
        </p>
        <p>
         Abnormalities that have been observed in animal models after induced neonatal seizures include reduced dendritic spine density in hippocampal pyramidal neurons, decreased neurogenesis, and altered hippocampal plasticity (eg, diminished capacity for long-term potentiation, reduced susceptibility to kindling and enhanced paired-pulse inhibition) [
         <a href="#rid81">
          81-84
         </a>
         ].
        </p>
        <p>
         In clinical practice it may appear that seizure duration influences outcome, since infants who experience brief and infrequent seizures can have relatively good long-term outcomes, while those with prolonged seizures may not do as well. However, transient causes (eg, glucose or electrolyte disturbances that have no associated permanent brain injury) may result in easily controlled seizures or self-limited seizures, while medically refractory neonatal seizures may be the result of more sustained, less treatable, or more severe brain disorders [
         <a href="#rid85">
          85
         </a>
         ]. Therefore, it is difficult to be certain about causation.
        </p>
        <p>
         Nonetheless, survivors of HIE who experienced severe neonatal seizures were reported to have a 30-point (2 standard deviations) lower full-scale intelligence quotient (IQ) at age four years, compared with those who were seizure-free in the neonatal period [
         <a href="#rid86">
          86
         </a>
         ]. Those with milder seizure burden still had lower IQs (by a full standard deviation) than children who were seizure free. These associations persisted after adjustment for neonatal MRI injury severity.
        </p>
        <p>
         Another study found that a greater burden of electrographic seizures correlated with a relative increase in mortality and morbidity in at-risk infants in general, and also in infants with perinatal asphyxia [
         <a href="#rid87">
          87
         </a>
         ]. Other investigations utilizing proton magnetic resonance spectroscopy (H-MRS) in neonates have found associations between seizure severity and both impaired cerebral metabolism (measured by lactate/choline) and compromised neuronal integrity (measured by N-acetylaspartate/choline) [
         <a href="#rid88">
          88
         </a>
         ]. These results suggest that brain injury is not limited to structural damage detected by MRI.
        </p>
        <p class="headingAnchor" id="H14">
         <span class="h2">
          Predictive variables
         </span>
        </p>
        <p class="headingAnchor" id="H15841724">
         <span class="h3">
          Clinical features
         </span>
         <span class="headingEndMark">
          —
         </span>
         The dominant factor that predicts outcome appears to be the underlying cause of the seizures rather than the presence, duration, or degree of brain involvement of the seizures themselves. In clinical studies, normal developmental outcomes are more likely when seizures are associated with hypoglycemia or hypocalcemia than when seizures occur in association with HIE, severe infection, or hemorrhage [
         <a href="#rid6">
          6,54,89-96
         </a>
         ].
        </p>
        <p>
         Seizure type may also predict outcome, due in part to the degree of CNS dysfunction typically associated with various categories of seizures [
         <a href="#rid62">
          62,63,97
         </a>
         ]. The presence of focal clonic and focal tonic seizures may suggest a relatively good outcome, primarily because these are typically associated with brain injury confined to one region, with spared CNS function in the remaining brain regions. However, focal tonic seizures are often associated with neonatal epilepsies that can portend significant neurodevelopmental impairment [
         <a href="#rid27">
          27
         </a>
         ]. Generalized tonic posturing, motor automatisms, and myoclonus suggest a poor outcome, since they are associated with diffuse CNS dysfunction. Similarly, multifocal seizures are associated with worse outcomes than unifocal seizures.
        </p>
        <p>
         A number of clinical variables in addition to etiology and character of the seizures may be predictors of outcome; these include [
         <a href="#rid9">
          9,53,54,63,96-100
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Seizure burden, including the number of sites of seizure onset and seizure duration
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Status epilepticus
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Neurologic examination at the time of seizures and at the time of hospital discharge
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Number of drugs required to treat seizures
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Findings on neuroimaging
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Gestational age (term versus preterm)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Birth weight
        </p>
        <p>
        </p>
        <p>
         Multiple, rather than single, factors appear to be most accurate in predicting outcome. However, all of these variables ultimately are related to the degree of brain injury at the time of seizure occurrence, and, in turn, the seizure etiology.
        </p>
        <p class="headingAnchor" id="H15841717">
         <span class="h3">
          EEG features
         </span>
         <span class="headingEndMark">
          —
         </span>
         The character of the interictal background EEG can be helpful in the determination of long-term outcome of infants who have experienced seizures.
        </p>
        <p>
         It is generally thought that the greater the EEG abnormality, the worse the prognosis. In making this determination, however, it is critical to take into consideration both the timing of the EEG in relation to the suspected time of injury and the rate of resolution of EEG abnormalities over time. An EEG performed early in the course of illness can be repeated several days later. The persistence of a diffuse EEG abnormality can suggest a poor prognosis, while its resolution suggests a better outcome. On the other hand, a normal initial EEG within 24 hours of birth reliably suggests a good prognosis.
        </p>
        <p>
         For newborns who receive therapeutic hypothermia for HIE, the recovery of EEG patterns may be delayed, with emergence of sleep-wake cycling in the second day of life [
         <a href="#rid101">
          101
         </a>
         ]. Still, persistent severe background abnormalities confer a high risk for adverse outcomes.
        </p>
        <p>
         Features of the ictal EEG that predict worse outcome include multifocal seizure onset and ictal spread to the contralateral hemisphere.
        </p>
        <p class="headingAnchor" id="H111412071">
         <span class="h1">
          SUMMARY
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Almost all neonatal seizures may be categorized as "symptomatic" (acute and reactive) seizures, occurring as a consequence of a specific identifiable etiology  (
         <a class="graphic graphic_table graphicRef73867" href="/z/d/graphic/73867.html" rel="external">
          table 1
         </a>
         and
         <a class="graphic graphic_table graphicRef76726" href="/z/d/graphic/76726.html" rel="external">
          table 2
         </a>
         ). (See
         <a class="local">
          'Classification'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Neonatal encephalopathy occurring as the result of hypoxia-ischemia is the most common cause of symptomatic neonatal seizures. Other common causes are ischemic or hemorrhagic stroke, metabolic disturbances, and central nervous system infection. Inborn errors of metabolism, although rare, are important to identify, since disease-modifying therapy may be available. (See
         <a class="local">
          'Acute provoked (symptomatic) seizures'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Three rare but distinct neonatal epilepsy syndromes are well recognized: benign familial neonatal epilepsy, early myoclonic encephalopathy, and early infantile epileptic encephalopathy. Genetic etiologies for these syndromes are being increasingly recognized. (See
         <a class="medical medical_review" href="/z/d/html/6198.html" rel="external">
          "Overview of neonatal epilepsy syndromes"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         There is a high incidence of early death (15 to 20 percent; higher for preterm infants) associated with neonatal seizures, as well as a high incidence of neurologic impairments (20 to 60 percent), cerebral palsy (up to 35 percent), developmental delay (up to 55 percent), and postneonatal epilepsy (13 to 27 percent) among survivors. (See
         <a class="local">
          'Prognosis'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         The most likely overriding factors that affect long-term outcome are the etiology of the seizures and the degree and distribution of brain injury caused by the underlying disturbance. The interictal EEG can also be useful in helping to predict long-term outcome. (See
         <a class="local">
          'Predictive variables'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H108049339">
         <span class="h1">
          ACKNOWLEDGMENT
         </span>
         <span class="headingEndMark">
          —
         </span>
         The UpToDate editorial staff acknowledges Dr. Eli Mizrahi, who contributed to an earlier version of this topic review.
        </p>
       </div>
       <div class="headingAnchor" id="references">
        <ol id="reference">
         <li class="breakAll">
          Mizrahi EM, Watanabe K. Symptomatic neonatal seizures. In: Epileptic syndromes in infancy, childhood and adolescence, 3rd, Roger J, Bureau M, Dravet CH, et al (Eds), John Libbey, 2002. p.15.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Scheffer IE, Berkovic S, Capovilla G, et al. ILAE classification of the epilepsies: Position paper of the ILAE Commission for Classification and Terminology. Epilepsia 2017; 58:512.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fisher RS, Cross JH, D'Souza C, et al. Instruction manual for the ILAE 2017 operational classification of seizure types. Epilepsia 2017; 58:531.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fisher RS, Cross JH, French JA, et al. Operational classification of seizure types by the International League Against Epilepsy: Position Paper of the ILAE Commission for Classification and Terminology. Epilepsia 2017; 58:522.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Zuberi SM, Wirrell E, Yozawitz E, et al. ILAE classification and definition of epilepsy syndromes with onset in neonates and infants: Position statement by the ILAE Task Force on Nosology and Definitions. Epilepsia 2022; 63:1349.
          </a>
         </li>
         <li class="breakAll">
          Mizrahi EM, Kellaway P. Diagnosis and Management of Neonatal Seizures, Lippincott-Raven, Philadelphia 1998. p.181.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Co JP, Elia M, Engel J Jr, et al. Proposal of an algorithm for diagnosis and treatment of neonatal seizures in developing countries. Epilepsia 2007; 48:1158.
          </a>
         </li>
         <li class="breakAll">
          Chapman KE, Mizrahi EM, Clancy RR. Neonatal seizures. In: Wyllie's Treatment of Epilepsy: Principles and Practice, 5th edition, Wyllie A, Cascino GD, Gidal BE, Goodkin HP (Eds), Lippincott, Williams &amp; Wilkens, Philadelphia 2011. p.405.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Glass HC, Shellhaas RA, Wusthoff CJ, et al. Contemporary Profile of Seizures in Neonates: A Prospective Cohort Study. J Pediatr 2016; 174:98.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rennie JM, de Vries LS, Blennow M, et al. Characterisation of neonatal seizures and their treatment using continuous EEG monitoring: a multicentre experience. Arch Dis Child Fetal Neonatal Ed 2019; 104:F493.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lynch NE, Stevenson NJ, Livingstone V, et al. The temporal evolution of electrographic seizure burden in neonatal hypoxic ischemic encephalopathy. Epilepsia 2012; 53:549.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Shankaran S, Laptook AR, Ehrenkranz RA, et al. Whole-body hypothermia for neonates with hypoxic-ischemic encephalopathy. N Engl J Med 2005; 353:1574.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Azzopardi D, Brocklehurst P, Edwards D, et al. The TOBY Study. Whole body hypothermia for the treatment of perinatal asphyxial encephalopathy: a randomised controlled trial. BMC Pediatr 2008; 8:17.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gluckman PD, Wyatt JS, Azzopardi D, et al. Selective head cooling with mild systemic hypothermia after neonatal encephalopathy: multicentre randomised trial. Lancet 2005; 365:663.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Glass HC, Wusthoff CJ, Shellhaas RA, et al. Risk factors for EEG seizures in neonates treated with hypothermia: a multicenter cohort study. Neurology 2014; 82:1239.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wusthoff CJ, Dlugos DJ, Gutierrez-Colina A, et al. Electrographic seizures during therapeutic hypothermia for neonatal hypoxic-ischemic encephalopathy. J Child Neurol 2011; 26:724.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Elshorbagy HH, Azab AA, Kamal NM, et al. Value of electroencephalographic monitoring in newborns with hypoxic-ischemic encephalopathy treated with hypothermia. J Pediatr Neurosci 2016; 11:309.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Benedetti GM, Vartanian RJ, McCaffery H, Shellhaas RA. Early Electroencephalogram Background Could Guide Tailored Duration of Monitoring for Neonatal Encephalopathy Treated with Therapeutic Hypothermia. J Pediatr 2020; 221:81.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kirton A, Armstrong-Wells J, Chang T, et al. Symptomatic neonatal arterial ischemic stroke: the International Pediatric Stroke Study. Pediatrics 2011; 128:e1402.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Harbison AL, Votava-Smith JK, Del Castillo S, et al. Clinical Factors Associated with Cerebral Metabolism in Term Neonates with Congenital Heart Disease. J Pediatr 2017; 183:67.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gaynor JW, Jarvik GP, Gerdes M, et al. Postoperative electroencephalographic seizures are associated with deficits in executive function and social behaviors at 4 years of age following cardiac surgery in infancy. J Thorac Cardiovasc Surg 2013; 146:132.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bellinger DC, Wypij D, Rivkin MJ, et al. Adolescents with d-transposition of the great arteries corrected with the arterial switch procedure: neuropsychological assessment and structural brain imaging. Circulation 2011; 124:1361.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Clancy RR, Sharif U, Ichord R, et al. Electrographic neonatal seizures after infant heart surgery. Epilepsia 2005; 46:84.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Naim MY, Gaynor JW, Chen J, et al. Subclinical seizures identified by postoperative electroencephalographic monitoring are common after neonatal cardiac surgery. J Thorac Cardiovasc Surg 2015; 150:169.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Andropoulos DB, Mizrahi EM, Hrachovy RA, et al. Electroencephalographic seizures after neonatal cardiac surgery with high-flow cardiopulmonary bypass. Anesth Analg 2010; 110:1680.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Simmons R, Martinez AB, Barkovich J, et al. Disorders of Neuronal Migration/Organization Convey the Highest Risk of Neonatal Onset Epilepsy Compared With Other Congenital Brain Malformations. Pediatr Neurol 2022; 127:20.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Shellhaas RA, Wusthoff CJ, Tsuchida TN, et al. Profile of neonatal epilepsies: Characteristics of a prospective US cohort. Neurology 2017; 89:893.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Verboon-Maciolek MA, Groenendaal F, Hahn CD, et al. Human parechovirus causes encephalitis with white matter injury in neonates. Ann Neurol 2008; 64:266.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Dhamija R, Patterson MC, Wirrell EC. Epilepsy in children--when should we think neurometabolic disease? J Child Neurol 2012; 27:663.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ficicioglu C, Bearden D. Isolated neonatal seizures: when to suspect inborn errors of metabolism. Pediatr Neurol 2011; 45:283.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mills PB, Struys E, Jakobs C, et al. Mutations in antiquitin in individuals with pyridoxine-dependent seizures. Nat Med 2006; 12:307.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mills PB, Footitt EJ, Mills KA, et al. Genotypic and phenotypic spectrum of pyridoxine-dependent epilepsy (ALDH7A1 deficiency). Brain 2010; 133:2148.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mefford HC, Zemel M, Geraghty E, et al. Intragenic deletions of ALDH7A1 in pyridoxine-dependent epilepsy caused by Alu-Alu recombination. Neurology 2015; 85:756.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           van Karnebeek CD, Tiebout SA, Niermeijer J, et al. Pyridoxine-Dependent Epilepsy: An Expanding Clinical Spectrum. Pediatr Neurol 2016; 59:6.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mills PB, Camuzeaux SS, Footitt EJ, et al. Epilepsy due to PNPO mutations: genotype, environment and treatment affect presentation and outcome. Brain 2014; 137:1350.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Plecko B, Paul K, Mills P, et al. Pyridoxine responsiveness in novel mutations of the PNPO gene. Neurology 2014; 82:1425.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Guerin A, Aziz AS, Mutch C, et al. Pyridox(am)ine-5-Phosphate Oxidase Deficiency Treatable Cause of Neonatal Epileptic Encephalopathy With Burst Suppression: Case Report and Review of the Literature. J Child Neurol 2015; 30:1218.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Basura GJ, Hagland SP, Wiltse AM, Gospe SM Jr. Clinical features and the management of pyridoxine-dependent and pyridoxine-responsive seizures: review of 63 North American cases submitted to a patient registry. Eur J Pediatr 2009; 168:697.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Schmitt B, Baumgartner M, Mills PB, et al. Seizures and paroxysmal events: symptoms pointing to the diagnosis of pyridoxine-dependent epilepsy and pyridoxine phosphate oxidase deficiency. Dev Med Child Neurol 2010; 52:e133.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bok LA, Halbertsma FJ, Houterman S, et al. Long-term outcome in pyridoxine-dependent epilepsy. Dev Med Child Neurol 2012; 54:849.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Stockler S, Plecko B, Gospe SM Jr, et al. Pyridoxine dependent epilepsy and antiquitin deficiency: clinical and molecular characteristics and recommendations for diagnosis, treatment and follow-up. Mol Genet Metab 2011; 104:48.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pérez B, Gutiérrez-Solana LG, Verdú A, et al. Clinical, biochemical, and molecular studies in pyridoxine-dependent epilepsy. Antisense therapy as possible new therapeutic option. Epilepsia 2013; 54:239.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Proudfoot M, Jardine P, Straukiene A, et al. Long-Term Follow-up of a Successfully Treated Case of Congenital Pyridoxine-Dependent Epilepsy. JIMD Rep 2013; 10:103.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Coughlin CR 2nd, van Karnebeek CD, Al-Hertani W, et al. Triple therapy with pyridoxine, arginine supplementation and dietary lysine restriction in pyridoxine-dependent epilepsy: Neurodevelopmental outcome. Mol Genet Metab 2015; 116:35.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Al Teneiji A, Bruun TU, Cordeiro D, et al. Phenotype, biochemical features, genotype and treatment outcome of pyridoxine-dependent epilepsy. Metab Brain Dis 2017; 32:443.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gallagher RC, Van Hove JL, Scharer G, et al. Folinic acid-responsive seizures are identical to pyridoxine-dependent epilepsy. Ann Neurol 2009; 65:550.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Schwarz G. Molybdenum cofactor biosynthesis and deficiency. Cell Mol Life Sci 2005; 62:2792.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Reiss J, Hahnewald R. Molybdenum cofactor deficiency: Mutations in GPHN, MOCS1, and MOCS2. Hum Mutat 2011; 32:10.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Schwahn BC, Van Spronsen FJ, Belaidi AA, et al. Efficacy and safety of cyclic pyranopterin monophosphate substitution in severe molybdenum cofactor deficiency type A: a prospective cohort study. Lancet 2015; 386:1955.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wilcken B. Treatments for rare diseases: molybdenum cofactor deficiency. Lancet 2015; 386:1924.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Veldman A, Santamaria-Araujo JA, Sollazzo S, et al. Successful treatment of molybdenum cofactor deficiency type A with cPMP. Pediatrics 2010; 125:e1249.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hitzert MM, Bos AF, Bergman KA, et al. Favorable outcome in a newborn with molybdenum cofactor type A deficiency treated with cPMP. Pediatrics 2012; 130:e1005.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mizrahi EM, Clancy RR. Neonatal seizures: early-onset seizure syndromes and their consequences for development. Ment Retard Dev Disabil Res Rev 2000; 6:229.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tekgul H, Gauvreau K, Soul J, et al. The current etiologic profile and neurodevelopmental outcome of seizures in term newborn infants. Pediatrics 2006; 117:1270.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Maartens IA, Wassenberg T, Buijs J, et al. Neurodevelopmental outcome in full-term newborns with refractory neonatal seizures. Acta Paediatr 2012; 101:e173.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lemmon ME, Bonifacio SL, Shellhaas RA, et al. Characterization of Death in Infants With Neonatal Seizures. Pediatr Neurol 2020; 113:21.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Glass HC, Shellhaas RA, Tsuchida TN, et al. Seizures in Preterm Neonates: A Multicenter Observational Cohort Study. Pediatr Neurol 2017; 72:19.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Buraniqi E, Sansevere AJ, Kapur K, et al. Electrographic Seizures in Preterm Neonates in the Neonatal Intensive Care Unit. J Child Neurol 2017; 32:880.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lloyd RO, O'Toole JM, Pavlidis E, et al. Electrographic Seizures during the Early Postnatal Period in Preterm Infants. J Pediatr 2017; 187:18.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ortibus EL, Sum JM, Hahn JS. Predictive value of EEG for outcome and epilepsy following neonatal seizures. Electroencephalogr Clin Neurophysiol 1996; 98:175.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Blume WT, Lüders HO, Mizrahi E, et al. Glossary of descriptive terminology for ictal semiology: report of the ILAE task force on classification and terminology. Epilepsia 2001; 42:1212.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Brunquell PJ, Glennon CM, DiMario FJ Jr, et al. Prediction of outcome based on clinical seizure type in newborn infants. J Pediatr 2002; 140:707.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ronen GM, Buckley D, Penney S, Streiner DL. Long-term prognosis in children with neonatal seizures: a population-based study. Neurology 2007; 69:1816.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mizrahi EM, Clancy RR, Dunn JK, et al. Neurological impairment, developmental delay and postnatal seizures 2 years after EEG-video documented seizures in near-term and term neonates: a report of the clinical research centers for neonatal seizures. Epilepsia 2001; 42(Supplement 7):102.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Davis AS, Hintz SR, Van Meurs KP, et al. Seizures in extremely low birth weight infants are associated with adverse outcome. J Pediatr 2010; 157:720.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Uria-Avellanal C, Marlow N, Rennie JM. Outcome following neonatal seizures. Semin Fetal Neonatal Med 2013; 18:224.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Garfinkle J, Shevell MI. Cerebral palsy, developmental delay, and epilepsy after neonatal seizures. Pediatr Neurol 2011; 44:88.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Shellhaas RA, Wusthoff CJ, Numis AL, et al. Early-life epilepsy after acute symptomatic neonatal seizures: A prospective multicenter study. Epilepsia 2021; 62:1871.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ellenberg JH, Hirtz DG, Nelson KB. Age at onset of seizures in young children. Ann Neurol 1984; 15:127.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bye AM, Cunningham CA, Chee KY, Flanagan D. Outcome of neonates with electrographically identified seizures, or at risk of seizures. Pediatr Neurol 1997; 16:225.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Scher MS, Aso K, Beggarly ME, et al. Electrographic seizures in preterm and full-term neonates: clinical correlates, associated brain lesions, and risk for neurologic sequelae. Pediatrics 1993; 91:128.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Clancy RR, Legido A. Postnatal epilepsy after EEG-confirmed neonatal seizures. Epilepsia 1991; 32:69.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pisani F, Cerminara C, Fusco C, Sisti L. Neonatal status epilepticus vs recurrent neonatal seizures: clinical findings and outcome. Neurology 2007; 69:2177.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Glass HC, Hong KJ, Rogers EE, et al. Risk factors for epilepsy in children with neonatal encephalopathy. Pediatr Res 2011; 70:535.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Watanabe K, Miura K, Natsume J, et al. Epilepsies of neonatal onset: seizure type and evolution. Dev Med Child Neurol 1999; 41:318.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Nunes ML, Martins MP, Barea BM, et al. Neurological outcome of newborns with neonatal seizures: a cohort study in a tertiary university hospital. Arq Neuropsiquiatr 2008; 66:168.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Glass HC, Grinspan ZM, Li Y, et al. Risk for infantile spasms after acute symptomatic neonatal seizures. Epilepsia 2020; 61:2774.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Inoue T, Shimizu M, Hamano S, et al. Epilepsy and West syndrome in neonates with hypoxic-ischemic encephalopathy. Pediatr Int 2014; 56:369.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Thibeault-Eybalin MP, Lortie A, Carmant L. Neonatal seizures: do they damage the brain? Pediatr Neurol 2009; 40:175.
          </a>
         </li>
         <li class="breakAll">
          Swann JW. Synaptogenesis and eliptogenesis in developing neural networks. In: Brain Development and Epilepsy, Schwartzkroin PA, Moshe SL, Noebels JL, Swann JW (Eds), Oxford University, New York 1995. p.195.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Jiang M, Lee CL, Smith KL, Swann JW. Spine loss and other persistent alterations of hippocampal pyramidal cell dendrites in a model of early-onset epilepsy. J Neurosci 1998; 18:8356.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           McCabe BK, Silveira DC, Cilio MR, et al. Reduced neurogenesis after neonatal seizures. J Neurosci 2001; 21:2094.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Montgomery EM, Bardgett ME, Lall B, et al. Delayed neuronal loss after administration of intracerebroventricular kainic acid to preweanling rats. Brain Res Dev Brain Res 1999; 112:107.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Holmes GL. The long-term effects of neonatal seizures. Clin Perinatol 2009; 36:901.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Glass HC, Wirrell E. Controversies in neonatal seizure management. J Child Neurol 2009; 24:591.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Glass HC, Glidden D, Jeremy RJ, et al. Clinical Neonatal Seizures are Independently Associated with Outcome in Infants at Risk for Hypoxic-Ischemic Brain Injury. J Pediatr 2009; 155:318.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           McBride MC, Laroia N, Guillet R. Electrographic seizures in neonates correlate with poor neurodevelopmental outcome. Neurology 2000; 55:506.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Miller SP, Weiss J, Barnwell A, et al. Seizure-associated brain injury in term newborns with perinatal asphyxia. Neurology 2002; 58:542.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           McInerny TK, Schubert WK. Prognosis of neonatal seizures. Am J Dis Child 1969; 117:261.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rose AL, Lombroso CT. A study of clinical, pathological, and electroencephalographic features in 137 full-term babies with a long-term follow-up. Pediatrics 1970; 45:404.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bergman I, Painter MJ, Hirsch RP, et al. Outcome in neonates with convulsions treated in an intensive care unit. Ann Neurol 1983; 14:642.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lombroso CT. Prognosis in neonatal seizures. Adv Neurol 1983; 34:101.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mannino FL, Trauner DA. Stroke in neonates. J Pediatr 1983; 102:605.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Clancy R, Malin S, Laraque D, et al. Focal motor seizures heralding stroke in full-term neonates. Am J Dis Child 1985; 139:601.
          </a>
         </li>
         <li class="breakAll">
          Kellaway P, Mizrahi EM. Neonatal seizures. In: Epilepsy: Electroclinical Syndromes, Luders H, Lesser RP (Eds), Springer-Verlag, New York 1987. p.13.
         </li>
         <li class="breakAll">
          Volpe JJ. Neurology of the Newborn. In: Neonatal Seizures, WB Sanders, Philadelphia 1995. p.172.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mizrahi EM, Kellaway P. Characterization and classification of neonatal seizures. Neurology 1987; 37:1837.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pisani F, Copioli C, Di Gioia C, et al. Neonatal seizures: relation of ictal video-electroencephalography (EEG) findings with neurodevelopmental outcome. J Child Neurol 2008; 23:394.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Holmes GL, Lombroso CT. Prognostic value of background patterns in the neonatal EEG. J Clin Neurophysiol 1993; 10:323.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Laroia N, Guillet R, Burchfiel J, McBride MC. EEG background as predictor of electrographic seizures in high-risk neonates. Epilepsia 1998; 39:545.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Thoresen M, Hellström-Westas L, Liu X, de Vries LS. Effect of hypothermia on amplitude-integrated electroencephalogram in infants with asphyxia. Pediatrics 2010; 126:e131.
          </a>
         </li>
        </ol>
       </div>
       <div id="topicVersionRevision">
        Topic 6179 Version 32.0
       </div>
      </div>
      <div class="row">
       <div class="col-12">
        <h4 style="text-align: center;padding: 20px;color: cadetblue;">
         References
        </h4>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="javascript:alert('بدون لینک');" id="rid0" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          1 : Mizrahi EM, Watanabe K. Symptomatic neonatal seizures. In: Epileptic syndromes in infancy, childhood and adolescence, 3rd, Roger J, Bureau M, Dravet CH, et al (Eds), John Libbey, 2002. p.15.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28276062" id="rid1" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          2 : ILAE classification of the epilepsies: Position paper of the ILAE Commission for Classification and Terminology.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28276064" id="rid2" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          3 : Instruction manual for the ILAE 2017 operational classification of seizure types.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28276060" id="rid3" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          4 : Operational classification of seizure types by the International League Against Epilepsy: Position Paper of the ILAE Commission for Classification and Terminology.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/35503712" id="rid4" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          5 : ILAE classification and definition of epilepsy syndromes with onset in neonates and infants: Position statement by the ILAE Task Force on Nosology and Definitions.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/35503712" id="rid5" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          6 : ILAE classification and definition of epilepsy syndromes with onset in neonates and infants: Position statement by the ILAE Task Force on Nosology and Definitions.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17442012" id="rid6" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          7 : Proposal of an algorithm for diagnosis and treatment of neonatal seizures in developing countries.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17442012" id="rid7" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          8 : Proposal of an algorithm for diagnosis and treatment of neonatal seizures in developing countries.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27106855" id="rid8" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          9 : Contemporary Profile of Seizures in Neonates: A Prospective Cohort Study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30472660" id="rid9" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          10 : Characterisation of neonatal seizures and their treatment using continuous EEG monitoring: a multicentre experience.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22309206" id="rid10" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          11 : The temporal evolution of electrographic seizure burden in neonatal hypoxic ischemic encephalopathy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16221780" id="rid11" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          12 : Whole-body hypothermia for neonates with hypoxic-ischemic encephalopathy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18447921" id="rid12" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          13 : The TOBY Study. Whole body hypothermia for the treatment of perinatal asphyxial encephalopathy: a randomised controlled trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15721471" id="rid13" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          14 : Selective head cooling with mild systemic hypothermia after neonatal encephalopathy: multicentre randomised trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24610326" id="rid14" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          15 : Risk factors for EEG seizures in neonates treated with hypothermia: a multicenter cohort study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21447810" id="rid15" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          16 : Electrographic seizures during therapeutic hypothermia for neonatal hypoxic-ischemic encephalopathy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28217152" id="rid16" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          17 : Value of electroencephalographic monitoring in newborns with hypoxic-ischemic encephalopathy treated with hypothermia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32222256" id="rid17" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          18 : Early Electroencephalogram Background Could Guide Tailored Duration of Monitoring for Neonatal Encephalopathy Treated with Therapeutic Hypothermia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22123886" id="rid18" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          19 : Symptomatic neonatal arterial ischemic stroke: the International Pediatric Stroke Study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28109537" id="rid19" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          20 : Clinical Factors Associated with Cerebral Metabolism in Term Neonates with Congenital Heart Disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23768805" id="rid20" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          21 : Postoperative electroencephalographic seizures are associated with deficits in executive function and social behaviors at 4 years of age following cardiac surgery in infancy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21875911" id="rid21" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          22 : Adolescents with d-transposition of the great arteries corrected with the arterial switch procedure: neuropsychological assessment and structural brain imaging.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15660772" id="rid22" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          23 : Electrographic neonatal seizures after infant heart surgery.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25957454" id="rid23" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          24 : Subclinical seizures identified by postoperative electroencephalographic monitoring are common after neonatal cardiac surgery.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20435942" id="rid24" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          25 : Electroencephalographic seizures after neonatal cardiac surgery with high-flow cardiopulmonary bypass.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/34933271" id="rid25" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          26 : Disorders of Neuronal Migration/Organization Convey the Highest Risk of Neonatal Onset Epilepsy Compared With Other Congenital Brain Malformations.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28733343" id="rid26" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          27 : Profile of neonatal epilepsies: Characteristics of a prospective US cohort.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18825694" id="rid27" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          28 : Human parechovirus causes encephalitis with white matter injury in neonates.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22378665" id="rid28" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          29 : Epilepsy in children--when should we think neurometabolic disease?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22000307" id="rid29" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          30 : Isolated neonatal seizures: when to suspect inborn errors of metabolism.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16491085" id="rid30" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          31 : Mutations in antiquitin in individuals with pyridoxine-dependent seizures.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20554659" id="rid31" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          32 : Genotypic and phenotypic spectrum of pyridoxine-dependent epilepsy (ALDH7A1 deficiency).
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26224730" id="rid32" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          33 : Intragenic deletions of ALDH7A1 in pyridoxine-dependent epilepsy caused by Alu-Alu recombination.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26995068" id="rid33" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          34 : Pyridoxine-Dependent Epilepsy: An Expanding Clinical Spectrum.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24645144" id="rid34" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          35 : Epilepsy due to PNPO mutations: genotype, environment and treatment affect presentation and outcome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24658933" id="rid35" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          36 : Pyridoxine responsiveness in novel mutations of the PNPO gene.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25296925" id="rid36" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          37 : Pyridox(am)ine-5-Phosphate Oxidase Deficiency Treatable Cause of Neonatal Epileptic Encephalopathy With Burst Suppression: Case Report and Review of the Literature.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18762976" id="rid37" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          38 : Clinical features and the management of pyridoxine-dependent and pyridoxine-responsive seizures: review of 63 North American cases submitted to a patient registry.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20370816" id="rid38" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          39 : Seizures and paroxysmal events: symptoms pointing to the diagnosis of pyridoxine-dependent epilepsy and pyridoxine phosphate oxidase deficiency.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22804844" id="rid39" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          40 : Long-term outcome in pyridoxine-dependent epilepsy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21704546" id="rid40" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          41 : Pyridoxine dependent epilepsy and antiquitin deficiency: clinical and molecular characteristics and recommendations for diagnosis, treatment and follow-up.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23350806" id="rid41" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          42 : Clinical, biochemical, and molecular studies in pyridoxine-dependent epilepsy. Antisense therapy as possible new therapeutic option.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23430810" id="rid42" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          43 : Long-Term Follow-up of a Successfully Treated Case of Congenital Pyridoxine-Dependent Epilepsy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26026794" id="rid43" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          44 : Triple therapy with pyridoxine, arginine supplementation and dietary lysine restriction in pyridoxine-dependent epilepsy: Neurodevelopmental outcome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27882480" id="rid44" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          45 : Phenotype, biochemical features, genotype and treatment outcome of pyridoxine-dependent epilepsy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19142996" id="rid45" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          46 : Folinic acid-responsive seizures are identical to pyridoxine-dependent epilepsy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16261263" id="rid46" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          47 : Molybdenum cofactor biosynthesis and deficiency.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21031595" id="rid47" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          48 : Molybdenum cofactor deficiency: Mutations in GPHN, MOCS1, and MOCS2.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26343839" id="rid48" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          49 : Efficacy and safety of cyclic pyranopterin monophosphate substitution in severe molybdenum cofactor deficiency type A: a prospective cohort study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26343841" id="rid49" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          50 : Treatments for rare diseases: molybdenum cofactor deficiency.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20385644" id="rid50" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          51 : Successful treatment of molybdenum cofactor deficiency type A with cPMP.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22987873" id="rid51" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          52 : Favorable outcome in a newborn with molybdenum cofactor type A deficiency treated with cPMP.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11107188" id="rid52" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          53 : Neonatal seizures: early-onset seizure syndromes and their consequences for development.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16585324" id="rid53" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          54 : The current etiologic profile and neurodevelopmental outcome of seizures in term newborn infants.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22085256" id="rid54" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          55 : Neurodevelopmental outcome in full-term newborns with refractory neonatal seizures.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32980743" id="rid55" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          56 : Characterization of Death in Infants With Neonatal Seizures.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28558955" id="rid56" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          57 : Seizures in Preterm Neonates: A Multicenter Observational Cohort Study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28691593" id="rid57" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          58 : Electrographic Seizures in Preterm Neonates in the Neonatal Intensive Care Unit.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28366355" id="rid58" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          59 : Electrographic Seizures during the Early Postnatal Period in Preterm Infants.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8631277" id="rid59" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          60 : Predictive value of EEG for outcome and epilepsy following neonatal seizures.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11580774" id="rid60" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          61 : Glossary of descriptive terminology for ictal semiology: report of the ILAE task force on classification and terminology.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12072874" id="rid61" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          62 : Prediction of outcome based on clinical seizure type in newborn infants.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17984448" id="rid62" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          63 : Long-term prognosis in children with neonatal seizures: a population-based study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid63" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          64 : Neurological impairment, developmental delay and postnatal seizures 2 years after EEG-video documented seizures in near-term and term neonates: a report of the clinical research centers for neonatal seizures
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20542294" id="rid64" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          65 : Seizures in extremely low birth weight infants are associated with adverse outcome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23466296" id="rid65" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          66 : Outcome following neonatal seizures.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21215907" id="rid66" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          67 : Cerebral palsy, developmental delay, and epilepsy after neonatal seizures.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/34212365" id="rid67" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          68 : Early-life epilepsy after acute symptomatic neonatal seizures: A prospective multicenter study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/6703653" id="rid68" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          69 : Age at onset of seizures in young children.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9165514" id="rid69" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          70 : Outcome of neonates with electrographically identified seizures, or at risk of seizures.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8416475" id="rid70" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          71 : Electrographic seizures in preterm and full-term neonates: clinical correlates, associated brain lesions, and risk for neurologic sequelae.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1985832" id="rid71" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          72 : Postnatal epilepsy after EEG-confirmed neonatal seizures.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18056582" id="rid72" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          73 : Neonatal status epilepticus vs recurrent neonatal seizures: clinical findings and outcome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21796017" id="rid73" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          74 : Risk factors for epilepsy in children with neonatal encephalopathy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10378757" id="rid74" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          75 : Epilepsies of neonatal onset: seizure type and evolution.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18545776" id="rid75" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          76 : Neurological outcome of newborns with neonatal seizures: a cohort study in a tertiary university hospital.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33188528" id="rid76" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          77 : Risk for infantile spasms after acute symptomatic neonatal seizures.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24274080" id="rid77" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          78 : Epilepsy and West syndrome in neonates with hypoxic-ischemic encephalopathy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19218030" id="rid78" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          79 : Neonatal seizures: do they damage the brain?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19218030" id="rid79" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          80 : Neonatal seizures: do they damage the brain?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9763479" id="rid80" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          81 : Spine loss and other persistent alterations of hippocampal pyramidal cell dendrites in a model of early-onset epilepsy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11245693" id="rid81" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          82 : Reduced neurogenesis after neonatal seizures.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9974164" id="rid82" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          83 : Delayed neuronal loss after administration of intracerebroventricular kainic acid to preweanling rats.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19944841" id="rid83" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          84 : The long-term effects of neonatal seizures.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19218527" id="rid84" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          85 : Controversies in neonatal seizure management.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19540512" id="rid85" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          86 : Clinical Neonatal Seizures are Independently Associated with Outcome in Infants at Risk for Hypoxic-Ischemic Brain Injury.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10953181" id="rid86" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          87 : Electrographic seizures in neonates correlate with poor neurodevelopmental outcome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11865130" id="rid87" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          88 : Seizure-associated brain injury in term newborns with perinatal asphyxia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/5765142" id="rid88" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          89 : Prognosis of neonatal seizures.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/5462600" id="rid89" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          90 : A study of clinical, pathological, and electroencephalographic features in 137 full-term babies with a long-term follow-up.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/6651249" id="rid90" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          91 : Outcome in neonates with convulsions treated in an intensive care unit.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/6829326" id="rid91" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          92 : Prognosis in neonatal seizures.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/6834199" id="rid92" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          93 : Stroke in neonates.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/4003365" id="rid93" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          94 : Focal motor seizures heralding stroke in full-term neonates.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/4003365" id="rid94" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          95 : Focal motor seizures heralding stroke in full-term neonates.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/4003365" id="rid95" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          96 : Focal motor seizures heralding stroke in full-term neonates.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3683874" id="rid96" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          97 : Characterization and classification of neonatal seizures.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18192647" id="rid97" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          98 : Neonatal seizures: relation of ictal video-electroencephalography (EEG) findings with neurodevelopmental outcome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8408599" id="rid98" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          99 : Prognostic value of background patterns in the neonatal EEG.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9596208" id="rid99" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          100 : EEG background as predictor of electrographic seizures in high-risk neonates.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20566612" id="rid100" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          101 : Effect of hypothermia on amplitude-integrated electroencephalogram in infants with asphyxia.
         </p>
        </a>
       </div>
      </div>
     </div>
    </div>
   </section>
  </section>
  <!-- End Main Menu Area -->
  <!-- Start Search Popup Area -->
  <!-- End Footer Area -->
  <!-- Back to top -->
  <a class="scrolltop" href="#top">
   <i class="icofont-hand-drawn-up">
   </i>
  </a>
  <!-- End Back to top -->
  <!-- jQuery Min JS -->
  <!-- Prpper JS -->
  <!-- Bootstrap Min JS -->
  <!-- Classy Nav Min Js -->
  <!-- Owl Carousel Min Js -->
  <!-- Magnific Popup JS -->
  <!-- CounterUp JS -->
  <!-- Waypoints JS -->
  <!-- Form Validator Min JS -->
  <!-- Contact Form Min JS -->
  <!-- Main JS -->
  <!-- Global site tag (gtag.js) - Google Analytics -->
 </body>
</html>
